Therapeutic antibodies for autoimmunity and inflammation.
about
Zika Virus: Medical Countermeasure Development ChallengesInhaled protein/peptide-based therapies for respiratory diseaseWhich New Health Technologies Do We Need to Achieve an End to HIV/AIDS?The role of Fc-FcγR interactions in IgG-mediated microbial neutralizationThe expanding role of immunopharmacology: IUPHAR Review 16Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsPharmacokinetic/pharmacodynamic modeling in inflammationInflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisIn vivo binding and retention of CD4-specific DARPin 57.2 in macaquesCD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytesImmunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and ProteinsAn indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitisA monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch reliefDesigning cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell bindingIdentification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activityHigh-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH regionFcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodiesComparative Evaluation of the Chemical Stability of 4 Well-Defined Immunoglobulin G1-Fc GlycoformsBioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids.Passive immunization against HIV/AIDS by antibody gene transfer.Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformMolecular Imaging of Pancreatic Cancer with Antibodies.A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypesUltrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imagingThe effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodiesDirect quantitative 13 C-filtered 1 H magnetic resonance imaging of PEGylated biomacromolecules in vivo.CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.Restoring the balance: immunotherapeutic combinations for autoimmune diseaseAntibody therapeutics targeting ion channels: are we there yet?Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding.Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsTertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiencyThe promise and challenge of high-throughput sequencing of the antibody repertoire.Target-selective joint polymerase chain reaction: a robust and rapid method for high-throughput production of recombinant monoclonal antibodies from single cells.A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles.
P2860
Q24261184-EA143589-9B98-429C-9D99-E30DD19453B9Q26751439-195ACEE9-C1D6-4772-AA0F-A72A01E8498AQ26765043-9DAF7219-AB5F-481F-A3A8-1CC89A25AB17Q26797466-00AF9D9A-E015-445C-9B53-9EDA1DB50213Q26801862-2AB5A033-C003-42E0-9B30-52EA20E60A62Q26822421-E4173232-2EFC-4365-9F46-E9B5F770E3C1Q26830621-D336FE84-561F-400C-83DD-219DD171B92FQ27001736-533AF24B-DD99-4298-9AF4-52157A9CA2E7Q27320871-11001428-CF17-45E6-A759-7CA0B88B3F2FQ27341786-715083C0-85BD-408A-AD98-0E169AF5E586Q28072319-04E23B78-B980-401B-ADFF-B8C6F894D3DEQ28079322-F7AE4E31-C44E-4F94-9BF9-171C27A2CA5BQ28240662-06C6D01D-1C61-4A01-9F74-38F5CEC5990EQ28252009-5F779F84-5F9C-4383-A3CB-00147A906C6CQ28487387-09C5BC92-CE1F-4A5F-9203-9E0509DC4173Q28709119-3E2FE487-CF8B-4885-BA38-848DDC23A5B0Q28730212-D8B1AE47-3F79-4778-AB9A-3889EC909F2AQ28820826-963D58A0-5255-48CD-8AD6-E404AFE7031BQ30279245-4EC6A87F-652E-4C4C-B6CC-B75E24A9C79FQ30358434-8644FED3-E360-44E1-A778-3C2890C56BBBQ30386192-5F1A18F6-11B9-4E8D-8CE6-332132599F64Q30393523-52B7FAAF-370A-40E7-9070-C8832FF12ECBQ30410546-2DF49C6D-B130-4C13-A8E6-623F247BC9CCQ30414837-6C77304B-9B6C-4C43-83B9-9C5791E0CC7DQ30422151-6667CE23-99C5-4CEA-9CCD-2363B175BC9BQ30559277-D00D50C0-4089-44E2-B0C4-A5DC1C080A7EQ30566003-BA3558AC-A170-43B4-ABFE-6504C7E8CA2CQ30818421-B3C8B313-7B29-4C8A-83AE-F7218C495250Q31077545-95DB8957-BE6B-4E38-AACD-93C6BD070A23Q31135534-E8DDA1A1-9EFD-46E5-AFB0-B342EE2BE97FQ33555986-23435E3B-99F2-41BC-A3AF-36F6C31E56ECQ33572352-CD087A16-7CB7-4B9F-80CF-931747D4BAEEQ33621610-DCA7ED66-BC34-490D-8462-D94B667521F3Q33676732-5CD521C6-F3B8-407C-9359-4E5D6DBDC61FQ33849404-D00E34EB-500B-41E2-A4F0-7303DC3FBD96Q33905411-67EE1016-15F0-4453-B3D0-2D62459A3A3BQ33942410-87AF88A3-3D59-451F-AF77-C1D69A85F532Q33962293-B37A9938-6184-4EB9-A89B-DA8AD1444B78Q33966567-AA543FE7-09BC-45E1-B900-B08762FDD2B7Q34001530-D8C097F1-FDA6-4530-93E2-66C626061D63
P2860
Therapeutic antibodies for autoimmunity and inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic antibodies for autoimmunity and inflammation.
@en
Therapeutic antibodies for autoimmunity and inflammation.
@nl
type
label
Therapeutic antibodies for autoimmunity and inflammation.
@en
Therapeutic antibodies for autoimmunity and inflammation.
@nl
prefLabel
Therapeutic antibodies for autoimmunity and inflammation.
@en
Therapeutic antibodies for autoimmunity and inflammation.
@nl
P356
P1476
Therapeutic antibodies for autoimmunity and inflammation.
@en
P2093
Andrew C Chan
Paul J Carter
P304
P356
10.1038/NRI2761
P577
2010-05-01T00:00:00Z